We next plan to link A1 NPs with some tumor targeting antibodies, such as anti-EGFR, anti-PMSA, anti-VEGF antibodies to construct tumor-targeted theranostic agents, as combination of both passive and active targeting approaches might further improve theranostic effect. This evidence concerns the gene EGFR and neoplasm.